Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

250.97
Delayed Data
As of Jul 21
 +1.90 / +0.76%
Today’s Change
184.50
Today|||52-Week Range
261.27
+19.50%
Year-to-Date

Today’s Trading

Previous close249.07
Today’s open248.99
Day’s range248.88 - 251.79
Volume2,509,879
Average volume (3 months)2,225,608
Market cap$84.3B
Dividend yield1.12%
Data as of 07/21/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.94%
Earnings growth (next 5 years)+14.85%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.16+0.47%
NVONovo Nordisk-0.60-1.38%
ABTAbbott Laboratories-0.01-0.02%
BMYBristol-Myers Squibb+0.21+0.38%
Data as of 8:33am ET, 07/24/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$3.92
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts